IRIS

Ertapenem versus piperacillin/tazobactam in the treatment of complicated intrabdominal infection:result of a double-blind, randomized comparative PhaseIII Trial , and the protocol 017 Study Group / Trignano, M., ET 017 STUDY, G.. - In: ANNALS OF SURGERY. - ISSN 0003-4932. - 237:(2003), pp. 235-245.

Ertapenem versus piperacillin/tazobactam in the treatment of complicated intrabdominal infection:result of a double-blind, randomized comparative PhaseIII Trial , and the protocol 017 Study Group

TRIGNANO, Mario;
2003-01-01
2003
Inglese
237
235
245
11
Sì, ma tipo non specificato
No
Trignano, Mario; ET 017 STUDY, Group
Ertapenem versus piperacillin/tazobactam in the treatment of complicated intrabdominal infection:result of a double-blind, randomized comparative PhaseIII Trial , and the protocol 017 Study Group / Trignano, M., ET 017 STUDY, G.. - In: ANNALS OF SURGERY. - ISSN 0003-4932. - 237:(2003), pp. 235-245.
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
2
none
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11388/150234
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact